Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Missing the old pharma swag? Take a trip down memory lane
Fierce Pharma Marketing
Wednesday, November 12, 2014 - 1:22pm
tags:
drug reps, pharma industry
Indian drugmakers see U.S. sales hit by delay in new approvals
Reuters
Wednesday, November 12, 2014 - 11:48am
tags:
India, FDA, drug approvals
Takeda's Millennium re-ups with Presage on cancer drug combo effort
Fierce Biotech
Wednesday, November 12, 2014 - 11:46am
tags:
Takeda, Millennium Pharmaceuticals, Presage Biosciences, cancer
Survey: Hospitals clamp down on medical device expenses
Mass Device
Wednesday, November 12, 2014 - 11:43am
tags:
devices
[video] What Makes Allergan an Attractive Target for Actavis?
Bloomberg
Wednesday, November 12, 2014 - 11:43am
tags:
Allergan, Actavis, M&A
Don’t expect a Dendreon sale; the troubled biotech will likely end up as a new entity with the current common shares cancelled
Barron's
Wednesday, November 12, 2014 - 11:02am
tags:
Dendreon, bankruptcy
Actavis Said in Talks to Acquire Allergan for Over $60 Billion
Bloomberg
Wednesday, November 12, 2014 - 10:50am
tags:
Actavis, Allergan, M&A
TEVA: Copaxone Patent Expiry Worries Are Overblown
Seeking Alpha
Wednesday, November 12, 2014 - 8:44am
tags:
Teva Pharmaceutical, Copaxone, MS, multiple sclerosis, patents
Should Johnson & Johnson Buy Medivation Inc.?
Motley Fool
Wednesday, November 12, 2014 - 8:41am
tags:
JNJ, Medivation, M&A, Xtandi, prostate cancer
Could Zoetis (ZTS) Be Ackman’s Next Pitch To Valeant Pharmaceuticals (VRX)?
Bidness Etc.
Wednesday, November 12, 2014 - 8:39am
tags:
Zoetis, Bill Ackman, M&A, Valeant Pharmaceuticals, animal health
Oxigene Faces Challenges for Ovarian Cancer Drug Even With Encouraging Data
TheStreet.com
Wednesday, November 12, 2014 - 8:38am
tags:
Oxigene, ovarian cancer, fosbretabulin, Avastin
Allergan amends shareholder meeting bylaws ahead of Dec. 18 meet
Yahoo/Reuters
Wednesday, November 12, 2014 - 8:35am
tags:
Allergan, Valeant Pharmaceuticals, shareholders, M&A
Avanir's AVP-825 Approval Could be Delayed
Yahoo/Zacks.com
Wednesday, November 12, 2014 - 8:35am
tags:
Avanir, AVP-825, migraines
Bristol-Myers Gives Updates on HCV Candidate Daclatasvir
Yahoo/Zacks.com
Wednesday, November 12, 2014 - 8:33am
tags:
Bristol-Myers Squibb, hepatitis C, daclatasvir
Amgen psoriasis drug tops J&J's Stelara in Phase III study
Yahoo/Reuters
Wednesday, November 12, 2014 - 8:32am
tags:
Amgen, psoriasis, JNJ, brodalumab, Stelara
Major Medical Centers ask Congress to Probe Genentech Distribution Shift
WSJ Pharmalot
Tuesday, November 11, 2014 - 3:41pm
tags:
Genentech, distribution, Ascension
Boston Scientific Shows Strength on Core Market Stabilization
Yahoo/Zacks.com
Tuesday, November 11, 2014 - 3:35pm
tags:
Boston Scientific, devices, earnings
AcelRx Pharmaceuticals (ACRX) Stock Rises After Third-Quarter Earnings Report
TheStreet.com
Tuesday, November 11, 2014 - 3:33pm
tags:
AcelRx, earnings
Takeda recruits GE to help discover new liver treatments
Fierce Biotech
Tuesday, November 11, 2014 - 1:17pm
tags:
Takeda, GE Healthcare, liver disease, diagnostics, R&D
Gilead hepatitis C drug highly effective in cirrhosis patients
Yahoo/Reuters
Tuesday, November 11, 2014 - 1:14pm
tags:
Gilead Sciences, cirrhosis, Harvoni

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.